Are the asthma guideline goals achieved in daily practice? A population-based study on treatment adequacy and the control of asthma

Roberto De Marco, Lucia Cazzoletti, Isa Cerveri, Angelo Corsico, Massimiliano Bugiani, Simone Accordini, Laura Carrozzi, Rossano Dallari, Aldo De Togni, Alessandra Marinoni, Pietro Pirina, Christer Janson

Research output: Contribution to journalArticle

Abstract

Background: The guidelines for asthma recommend that the use of anti-inflammatory therapy should be adapted to the severity of the disease. However, few data are available to assess the adequacy of the use of drugs and its influence on the control of asthma in 'real life'. Methods: The adequacy of the current use of anti-asthmatic medication according to the Global Initiative for Asthma (GINA) guidelines was assessed in a random sample of 400 asthmatics identified in the frame of the Italian Study on Asthma in Young Adults. Asthma severity was assessed using the GINA criteria; accordingly, a patient was classified as receiving inadequate treatment if his/ her current use of drugs was lower than that suggested by the guidelines for the corresponding severity level. The absence of asthma attacks in the last 3 months was used as an indicator of the disease control. Results: Fifty-five percent of the patients had persistent asthma. Overall, 48% (95% CI 41.2-54.8) of persistent asthmatics were receiving inadequate treatment, and 66% (95% CI 59.5-72.4) had not used their medication daily over the past 3 months. Persistent asthmatics who were inadequately treated had a significantly greater frequency of asthma attacks (geometric mean ratio 3.7; 95% CI 2.1-6.6) than those using an adequate dose of medication. Mild and moderate persistent asthmatics using an adequate medication regimen reported a low number of asthma attacks (median 0). At the multivariate analysis, a good control of the disease was positively associated with an adequate dose of anti-inflammatory medication (OR = 2.2; 95% CI 1.1-4.5) and was negatively associated with a later onset of asthma (OR = 0.96; 95% CI 0.93-0.99) and severe asthma (OR = 0.37; 95% CI 0.17-0.81). Conclusions: Despite the increase in the use of inhaled corticosteroids, half of the persistent asthmatics from the general population are using a medication regimen below their severity level. When the use of drugs follows the GINA guideline recommendations, a good control of asthma is also achievable in the daily management of the disease, particularly in the case of mild and moderate asthmatics.

Original languageEnglish
Pages (from-to)225-234
Number of pages10
JournalInternational Archives of Allergy and Immunology
Volume138
Issue number3
DOIs
Publication statusPublished - Nov 2005

Fingerprint

Asthma
Guidelines
Population
Therapeutics
Anti-Inflammatory Agents
Pharmaceutical Preparations
Anti-Asthmatic Agents
Disease Management
Young Adult
Adrenal Cortex Hormones
Multivariate Analysis

Keywords

  • Asthma control
  • Asthma epidemiology
  • Asthma severity classification
  • Drug therapy
  • Treatment appropriateness

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Are the asthma guideline goals achieved in daily practice? A population-based study on treatment adequacy and the control of asthma. / De Marco, Roberto; Cazzoletti, Lucia; Cerveri, Isa; Corsico, Angelo; Bugiani, Massimiliano; Accordini, Simone; Carrozzi, Laura; Dallari, Rossano; De Togni, Aldo; Marinoni, Alessandra; Pirina, Pietro; Janson, Christer.

In: International Archives of Allergy and Immunology, Vol. 138, No. 3, 11.2005, p. 225-234.

Research output: Contribution to journalArticle

De Marco, R, Cazzoletti, L, Cerveri, I, Corsico, A, Bugiani, M, Accordini, S, Carrozzi, L, Dallari, R, De Togni, A, Marinoni, A, Pirina, P & Janson, C 2005, 'Are the asthma guideline goals achieved in daily practice? A population-based study on treatment adequacy and the control of asthma', International Archives of Allergy and Immunology, vol. 138, no. 3, pp. 225-234. https://doi.org/10.1159/000088723
De Marco, Roberto ; Cazzoletti, Lucia ; Cerveri, Isa ; Corsico, Angelo ; Bugiani, Massimiliano ; Accordini, Simone ; Carrozzi, Laura ; Dallari, Rossano ; De Togni, Aldo ; Marinoni, Alessandra ; Pirina, Pietro ; Janson, Christer. / Are the asthma guideline goals achieved in daily practice? A population-based study on treatment adequacy and the control of asthma. In: International Archives of Allergy and Immunology. 2005 ; Vol. 138, No. 3. pp. 225-234.
@article{5abd53d7520247bf837ff6f5f226fe46,
title = "Are the asthma guideline goals achieved in daily practice? A population-based study on treatment adequacy and the control of asthma",
abstract = "Background: The guidelines for asthma recommend that the use of anti-inflammatory therapy should be adapted to the severity of the disease. However, few data are available to assess the adequacy of the use of drugs and its influence on the control of asthma in 'real life'. Methods: The adequacy of the current use of anti-asthmatic medication according to the Global Initiative for Asthma (GINA) guidelines was assessed in a random sample of 400 asthmatics identified in the frame of the Italian Study on Asthma in Young Adults. Asthma severity was assessed using the GINA criteria; accordingly, a patient was classified as receiving inadequate treatment if his/ her current use of drugs was lower than that suggested by the guidelines for the corresponding severity level. The absence of asthma attacks in the last 3 months was used as an indicator of the disease control. Results: Fifty-five percent of the patients had persistent asthma. Overall, 48{\%} (95{\%} CI 41.2-54.8) of persistent asthmatics were receiving inadequate treatment, and 66{\%} (95{\%} CI 59.5-72.4) had not used their medication daily over the past 3 months. Persistent asthmatics who were inadequately treated had a significantly greater frequency of asthma attacks (geometric mean ratio 3.7; 95{\%} CI 2.1-6.6) than those using an adequate dose of medication. Mild and moderate persistent asthmatics using an adequate medication regimen reported a low number of asthma attacks (median 0). At the multivariate analysis, a good control of the disease was positively associated with an adequate dose of anti-inflammatory medication (OR = 2.2; 95{\%} CI 1.1-4.5) and was negatively associated with a later onset of asthma (OR = 0.96; 95{\%} CI 0.93-0.99) and severe asthma (OR = 0.37; 95{\%} CI 0.17-0.81). Conclusions: Despite the increase in the use of inhaled corticosteroids, half of the persistent asthmatics from the general population are using a medication regimen below their severity level. When the use of drugs follows the GINA guideline recommendations, a good control of asthma is also achievable in the daily management of the disease, particularly in the case of mild and moderate asthmatics.",
keywords = "Asthma control, Asthma epidemiology, Asthma severity classification, Drug therapy, Treatment appropriateness",
author = "{De Marco}, Roberto and Lucia Cazzoletti and Isa Cerveri and Angelo Corsico and Massimiliano Bugiani and Simone Accordini and Laura Carrozzi and Rossano Dallari and {De Togni}, Aldo and Alessandra Marinoni and Pietro Pirina and Christer Janson",
year = "2005",
month = "11",
doi = "10.1159/000088723",
language = "English",
volume = "138",
pages = "225--234",
journal = "International Archives of Allergy and Immunology",
issn = "1018-2438",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - Are the asthma guideline goals achieved in daily practice? A population-based study on treatment adequacy and the control of asthma

AU - De Marco, Roberto

AU - Cazzoletti, Lucia

AU - Cerveri, Isa

AU - Corsico, Angelo

AU - Bugiani, Massimiliano

AU - Accordini, Simone

AU - Carrozzi, Laura

AU - Dallari, Rossano

AU - De Togni, Aldo

AU - Marinoni, Alessandra

AU - Pirina, Pietro

AU - Janson, Christer

PY - 2005/11

Y1 - 2005/11

N2 - Background: The guidelines for asthma recommend that the use of anti-inflammatory therapy should be adapted to the severity of the disease. However, few data are available to assess the adequacy of the use of drugs and its influence on the control of asthma in 'real life'. Methods: The adequacy of the current use of anti-asthmatic medication according to the Global Initiative for Asthma (GINA) guidelines was assessed in a random sample of 400 asthmatics identified in the frame of the Italian Study on Asthma in Young Adults. Asthma severity was assessed using the GINA criteria; accordingly, a patient was classified as receiving inadequate treatment if his/ her current use of drugs was lower than that suggested by the guidelines for the corresponding severity level. The absence of asthma attacks in the last 3 months was used as an indicator of the disease control. Results: Fifty-five percent of the patients had persistent asthma. Overall, 48% (95% CI 41.2-54.8) of persistent asthmatics were receiving inadequate treatment, and 66% (95% CI 59.5-72.4) had not used their medication daily over the past 3 months. Persistent asthmatics who were inadequately treated had a significantly greater frequency of asthma attacks (geometric mean ratio 3.7; 95% CI 2.1-6.6) than those using an adequate dose of medication. Mild and moderate persistent asthmatics using an adequate medication regimen reported a low number of asthma attacks (median 0). At the multivariate analysis, a good control of the disease was positively associated with an adequate dose of anti-inflammatory medication (OR = 2.2; 95% CI 1.1-4.5) and was negatively associated with a later onset of asthma (OR = 0.96; 95% CI 0.93-0.99) and severe asthma (OR = 0.37; 95% CI 0.17-0.81). Conclusions: Despite the increase in the use of inhaled corticosteroids, half of the persistent asthmatics from the general population are using a medication regimen below their severity level. When the use of drugs follows the GINA guideline recommendations, a good control of asthma is also achievable in the daily management of the disease, particularly in the case of mild and moderate asthmatics.

AB - Background: The guidelines for asthma recommend that the use of anti-inflammatory therapy should be adapted to the severity of the disease. However, few data are available to assess the adequacy of the use of drugs and its influence on the control of asthma in 'real life'. Methods: The adequacy of the current use of anti-asthmatic medication according to the Global Initiative for Asthma (GINA) guidelines was assessed in a random sample of 400 asthmatics identified in the frame of the Italian Study on Asthma in Young Adults. Asthma severity was assessed using the GINA criteria; accordingly, a patient was classified as receiving inadequate treatment if his/ her current use of drugs was lower than that suggested by the guidelines for the corresponding severity level. The absence of asthma attacks in the last 3 months was used as an indicator of the disease control. Results: Fifty-five percent of the patients had persistent asthma. Overall, 48% (95% CI 41.2-54.8) of persistent asthmatics were receiving inadequate treatment, and 66% (95% CI 59.5-72.4) had not used their medication daily over the past 3 months. Persistent asthmatics who were inadequately treated had a significantly greater frequency of asthma attacks (geometric mean ratio 3.7; 95% CI 2.1-6.6) than those using an adequate dose of medication. Mild and moderate persistent asthmatics using an adequate medication regimen reported a low number of asthma attacks (median 0). At the multivariate analysis, a good control of the disease was positively associated with an adequate dose of anti-inflammatory medication (OR = 2.2; 95% CI 1.1-4.5) and was negatively associated with a later onset of asthma (OR = 0.96; 95% CI 0.93-0.99) and severe asthma (OR = 0.37; 95% CI 0.17-0.81). Conclusions: Despite the increase in the use of inhaled corticosteroids, half of the persistent asthmatics from the general population are using a medication regimen below their severity level. When the use of drugs follows the GINA guideline recommendations, a good control of asthma is also achievable in the daily management of the disease, particularly in the case of mild and moderate asthmatics.

KW - Asthma control

KW - Asthma epidemiology

KW - Asthma severity classification

KW - Drug therapy

KW - Treatment appropriateness

UR - http://www.scopus.com/inward/record.url?scp=27544474264&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27544474264&partnerID=8YFLogxK

U2 - 10.1159/000088723

DO - 10.1159/000088723

M3 - Article

C2 - 16210861

AN - SCOPUS:27544474264

VL - 138

SP - 225

EP - 234

JO - International Archives of Allergy and Immunology

JF - International Archives of Allergy and Immunology

SN - 1018-2438

IS - 3

ER -